Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Digestion
|
January 1, 1977
HLA and chronic active hepatitis
M C Mazzilli, S Trabace, F D Raimondo, et al.
Cell Proliferation
|
September 1, 1992
Altered proliferative kinetics in PHA-activated human T-lymphocytes treated with the anti-HLA class I monoclonal antibody 01.65
M Rubini, R Selvatici, P Orlando, et al.
Biochemistry International
|
January 1, 1991
Competitive effect of anti-HLA class I monoclonal antibody (01.65) and N-N-staurosporine on prolipherative response of PHA activated T-lymphocytes
R Selvatici, P Orlando, M Rubini, et al.
Biochemical and Biophysical Research Communications
|
October 15, 1992
Anchored anti-HLA class I monoclonal antibody fails to induce inhibition of PHA-activated lymphocytes proliferation
M Rubini, R Selvatici, P Orlando, et al.
FEBS Letters
|
August 30, 1993
Identification of a novel protein kinase C inhibitor in microsomes from phytohaemagglutinin activated human peripheral blood mononuclear cells
E Gandini, P Orlando, R Selvatici, et al.
Human Genetics
|
January 1, 1985
Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes
B Dallapiccola, B Porfirio, V Mokini, et al.
Contributions to Nephrology
|
January 1, 1992
Peculiar type of focal and segmental lupus glomerulitis: glomerulonephritis or vasculitis?
F Ferrario, P Napodano, A Giordano, et al.
Biochemical and Biophysical Research Communications
|
July 29, 1988
Monoclonal antibodies against HLA class I antigens inhibit human lymphocyte proliferation but do not affect mitogen dependent second messenger generation
G Cavallini, T Pozzan, R Selvatici, et al.
Clinical Nephrology
|
April 1, 1996
Minimal change nephrotic syndrome with cecum adenocarcinoma
E Gandini, P Allaria, A Castiglioni, et al.
Biochemistry International
|
September 1, 1991
Molecular analysis of cell cycle-related gene expression in anti-HLA class I monoclonal antibody (01.65) treated PHA-activated human T-lymphocytes
R Selvatici, M Rubini, P Orlando, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Digestion
|
January 1, 1977
HLA and chronic active hepatitis
M C Mazzilli, S Trabace, F D Raimondo, et al.
Cell Proliferation
|
September 1, 1992
Altered proliferative kinetics in PHA-activated human T-lymphocytes treated with the anti-HLA class I monoclonal antibody 01.65
M Rubini, R Selvatici, P Orlando, et al.
Biochemistry International
|
January 1, 1991
Competitive effect of anti-HLA class I monoclonal antibody (01.65) and N-N-staurosporine on prolipherative response of PHA activated T-lymphocytes
R Selvatici, P Orlando, M Rubini, et al.
Biochemical and Biophysical Research Communications
|
October 15, 1992
Anchored anti-HLA class I monoclonal antibody fails to induce inhibition of PHA-activated lymphocytes proliferation
M Rubini, R Selvatici, P Orlando, et al.
FEBS Letters
|
August 30, 1993
Identification of a novel protein kinase C inhibitor in microsomes from phytohaemagglutinin activated human peripheral blood mononuclear cells
E Gandini, P Orlando, R Selvatici, et al.
Human Genetics
|
January 1, 1985
Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes
B Dallapiccola, B Porfirio, V Mokini, et al.
Contributions to Nephrology
|
January 1, 1992
Peculiar type of focal and segmental lupus glomerulitis: glomerulonephritis or vasculitis?
F Ferrario, P Napodano, A Giordano, et al.
Biochemical and Biophysical Research Communications
|
July 29, 1988
Monoclonal antibodies against HLA class I antigens inhibit human lymphocyte proliferation but do not affect mitogen dependent second messenger generation
G Cavallini, T Pozzan, R Selvatici, et al.
Clinical Nephrology
|
April 1, 1996
Minimal change nephrotic syndrome with cecum adenocarcinoma
E Gandini, P Allaria, A Castiglioni, et al.
Biochemistry International
|
September 1, 1991
Molecular analysis of cell cycle-related gene expression in anti-HLA class I monoclonal antibody (01.65) treated PHA-activated human T-lymphocytes
R Selvatici, M Rubini, P Orlando, et al.
Page
of 6